Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

75.57
Delayed Data
As of Sep 23
 -1.52 / -1.97%
Today’s Change
49.96
Today|||52-Week Range
110.75
-19.73%
Year-to-Date
Better Buy: Ziopharm Oncology, Inc. vs. Alnylam Pharmaceuticals, Inc.
Sep 24 / MotleyFool.com - Paid Partner Content
3 Ways Ionis Pharmaceuticals, Inc. Is Beating the Competition
Sep 19 / MotleyFool.com - Paid Partner Content